Comment on Englewood's Aytu BioScience acquires Primsol liquid antibiotic

Englewood's Aytu BioScience acquires Primsol liquid antibiotic

Aytu BioScience Inc. acquired the rights to urinary tract infection drug Primsol, broadening the Englewood-based firm's portfolio of urology products, officials announced Tuesday.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News